BVL3572S
BVL3572S, a hydroxamic acid derivative, exhibits potent bactericidal activity against Mycobacterium tuberculosis (Mtb) with a MIC90 of 1.7 µM. BVL3572S inhibits pyridoxal phosphate (PLP) -dependent aminotransferases HisC and AlaA to kill Mtb. BVL3572S can be used for tuberculosis (TB) research[1].
Product Specifications
CAS Number
[1258544-63-6]
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Inflammation/Immunology
Smiles
ON1C2=CC(Br)=CC=C2C[C@H](N)C1=O
Molecular Formula
C9H9BrN2O2
Molecular Weight
257.08
References & Citations
[1]Zainab Edoo, et al. Exploiting Vitamin B6 Dependency: BVL3572S Inhibits HisC and AlaA to Kill Mycobacterium. bioRxiv. October 27, 2025.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W791994A/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal CUEDC2 Antibody (08) [DyLight 594]](https://cdn.genprice.uk/genprice/genprice4.png)
![Rabbit Polyclonal Seladin 1 Antibody [Allophycocyanin]](https://cdn.genprice.uk/genprice/genprice5.png)
AP73407 Inquire
Recombinant Human Glial cell line-derived neurotrophic factor protein (GDNF) (Active)
Ask
View Details MBS2078048-01 0.1 mL
APC-Linked Polyclonal Antibody to Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2)
Ask
View Details